Відео

Vera's lead clinical candidate is atacicept, a recombinant TACI-Fc fusion protein that is a dual inhibitor of BAFF (B cell activating factor, also known as BLyS or B lymphocyte stimulator) and APRIL (A proliferation inducing ligand). These cytokines activate B cells and plasma cells to produce disease-causing antibodies. Atacicept is uniquely able to substantially reduce galactose deficient-IgA...

Three years after Claire Flores donated a kidney to her husband, a BK Virus infection took his life. Her story illustrates the urgent need for effective treatments for BK Virus, which is a common cause of kidney transplant loss. There are currently no approved treatments for BK Virus. To learn more about Vera's commitment to helping patients with immunologic diseases, visit veratx.com.

Listen to Liz talk about what it's like to live with IgA nephropathy. Visit our website to read stories from other individuals with IgA nephropathy: veratx.com/patients/